FindTrial
Sign In

A prospective cohort study to evaluate hair loss and skin change in breast cancer patients

Prospective cohort study for the evaluation of quality of life (QOL) of breast cancer patient who underwent of surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007989
Enrollment
20000
Registered
2022-12-09
Start date
2019-08-20
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients above 18 years of age with a postoperative diagnosis of stage I–III breast cancer, who received neo-adjuvant treatment or were scheduled to receive adjuvant treatment

Exclusion criteria

Exclusion criteria: Patients with skin diseases including acne, rosacea, atopic dermatitis, psoriasis, as well as those using minoxidil, antihistamines, steroids, anticonvulsants, or antidepressants.

Design outcomes

Primary

MeasureTime frame
The extent of hair loss—

Secondary

MeasureTime frame
Skin changes—

Countries

Korea, Republic of

Contacts

Public ContactHyungrye Noh

Samsung Medical Center

skykavin@naver.com+82-2-3410-6578

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026